Bone Mineral Density Values Using Radiofrequency Echographic Multi-Spectrometry in Premenopausal Breast Cancer Patients Receiving Tamoxifen Therapy
Downloads
Background: Breast cancer (BC) is the most prevalent malignancy in women. Tamoxifen produces varying effects on the bone according to menopausal status. This study was performed at Adam Malik Hospital to analyze the risk factors for osteoporosis, focusing on bone mineral density (BMD) and length of tamoxifen therapy in premenopausal breast cancer patients. This research also used radiofrequency echographic multi-spectrometry (REMS) to evaluate BMD as a potential alternative to dual x-ray absorptiometry (DXA) in the diagnosis of osteoporosis patients.
Methods: This case-control study analyzed and interviewed 20 premenopausal breast cancer patients who received at least one year of tamoxifen therapy. The stadium of cancer, type of tamoxifen therapy, and BMD of each patient were determined using REMS.
Results: The study of 20 breast cancer patients showed a mean age of 50.4 ± 5.61 years. The average length of tamoxifen therapy was 2.65 years, with a standard deviation of 1.13 years. Most patients presented with osteopenia status, namely 16 patients (80%), whereas three patients (15%) of the total sample presented with osteoporosis. REMS showed excellent accuracy in distinguishing between various tissue types, providing detailed information on tissue composition and structure.
Conclusions: Based on the conducted research, it was determined that the use of tamoxifen for more than four years in premenopausal breast cancer patients influenced the incidence of osteoporosis. REMS shows potential as an alternative to DXA for the diagnosis of osteoporosis.
Shang C, Xu D. Epidemiology of breast cancer. Oncologie. 2022;24(4):649–63.
Ramchand SK, Cheung YM, Yeo B, Grossmann M. The effects of adjuvant endocrine therapy on bone health in women with breast cancer. J Endocrinol. 2019;241(3):R111-24.
Idaiani S, Delima D. The prevalence of breast tumors: An Indonesia non communicable disease survey. Ann Oncol. 2018 Nov;29:ix122.
Lee J, Alqudaihi HM, Kang MS, Kim J, Lee JW, Ko BS, et al. Effect of tamoxifen on the risk of osteoporosis and osteoporotic fracture in younger breast cancer survivors: a nationwide study. Front Oncol. 2020;10:366.
Iwaszkiewicz C, Leszczyński P. Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in the diagnosis of osteoporosis. Forum Reumatol. 2019;5(2):81-8.
Al Refaie A, Baldassini L, Mondillo C, Giglio E, De Vita M, Tomai Pitinca MD, et al. Radiofrequency echographic multi spectrometry (R.E.M.S.): new frontiers for ultrasound use in the assessment of bone status-a current picture. Diagnostics (Basel). 2023 May 9;13(10):1666.
Khu A, Sumardi M. A REMS scan-based report on relation between body mass index and osteoporosis in urban population of Medan at Royal Prima Hospital. Maj Kedokt Bandung. 2020;52(1):22-7.
Fuggle NR, Reginster JY, Al-Daghri N, Bruyere O, Burlet N, Campusano C, et al. Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art. Aging Clin Exp Res. 2024;36(1):135.
Günaldı M, Erkisi M, Afşar CU, Erçolak V, Paydas S, Kara IO, et al. Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology. 2014;94(3-4):183-9.
Shapiro CL. Osteoporosis: a long-term and late-effect of breast cancer treatments. Cancers (Basel). 2020;12(11):3094.
Alizadeh M, Ghojazadeh M, Piri R, Mirza-Aghazadeh-Attari M, Mohammadi S, Naghavi-Behzad M. Age at diagnosis of breast cancer in Iran: a systematic review and meta-analysis. Iran J Public Health. 2021;50(8):1564-76.
Dal Berto M, Dos Santos GT, Dos Santos AV, Silva AO, Vargas JE, Alves RJV, et al. Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis. Discov Oncol. 2021;12(1):37.
Lee SJ, Cha CD, Hong H, Choi YY, Chung MS. Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis. Breast Cancer. 2024;31:717-25.
Copyright (c) 2025 Journal Orthopaedi and Traumatology Surabaya
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (